Navigation Links
Family Tree May Aid Treatment of Inherited Heart Disorders
Date:2/28/2012

TUESDAY, Feb. 28 (HealthDay News) -- Researchers who used family trees dating back to 1811 to estimate the death risk for people with inherited heart rhythm disorders say their findings can help doctors determine when to screen and treat today's patients with these disorders.

Sudden cardiac death can occur in apparently healthy people due to heart rhythm disorders. Genetic testing can identify people with an inherited heart rhythm disorder (arrhythmia), but that raises questions about how and when to treat children who may not yet be experiencing symptoms, which can take years to develop.

In the study, researchers used Dutch archives to reconstruct the family trees for patients with inherited heart conditions, including long QT syndrome, SCN5a-overlap syndrome, CPVT and Brugada syndrome. The arrhythmia-associated gene mutations examined in the study are rare. However, the children of people who carry one of these mutations have a 50 percent chance of inheriting it.

The investigators were able to identify age ranges that were associated with an increased risk of death among people who had the mutations but had not yet been diagnosed or treated for the condition.

Among the findings:

  • The death risk for people with long QT syndrome -- a condition related to sudden infant death syndrome -- was high between 1 and 19 years old, but was particularly high in the first 10 years of life for those with a specific mutation (LQTS1). The risk of death for people with two other mutations (LQTS2 and LQTS3) didn't significantly increase until they were teens or adults.
  • For people with SCN5a-overlap syndrome, death risk started to rise at age 5 and became significant between ages 10 to 59, with a peak between ages 20 to 39. People with this condition have a gene mutation that affects the way heart cells respond to the heart's internal electrical current.
  • Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a condition that causes fainting, often during exercise or strong emotions. Death risk for people with this condition was highest between ages 20 to 39.
  • Brugada syndrome causes fainting and a rapid heart rhythm that can lead to sudden cardiac death. The risk of death for people with this condition was highest between ages 40 to 59. Males were at greatest risk.

The study appears in the current issue of the journal Circulation: Cardiovascular Genetics.

"We have to be careful not to draw conclusions for families with arrhythmias caused by different mutations," lead researcher Dr. Eline Nannenberg, a clinical geneticist at the Academic Medical Center in Amsterdam, said in a journal news release.

"However, this new data can guide screening. In LQTS1, we advise starting genetic and heart screening of first-degree family members (children, siblings, parents) at a very young age," Nannenberg added.

Female patients who have Brugada syndrome but no symptoms may not need invasive treatment for the first 30 years of life, but should follow standard prevention measures, such as fighting fever, according to the researchers.

In people with SCN5a-overlap syndrome, it may be possible to delay implantation of a pacemaker or implantable cardioverter-defibrillator (ICD) until after age 5, they noted.

More information

The Heart Rhythm Society has more about heart rhythm disorders.

-- Robert Preidt

SOURCE: Circulation: Cardiovascular Genetics, news release, Feb. 28, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Rutgers study finds paid family leave leads to positive economic outcomes
2. January/February 2012 Annals of Family Medicine
3. Family Tips for Getting Fit
4. Improving family consent in organ donation could save lives
5. Key genetic error found in family of blood cancers
6. Family Tree May Affect Diagnosis Age in Some Breast Cancers
7. New research sheds light on how we see family resemblance in faces
8. November/December 2011 Annals of Family Medicine Tip Sheet
9. Drinking Risky for Women With Family History of Breast Cancer: Study
10. Girls with family history of breast disease should avoid alcohol
11. Life beyond cancer: Starting a family following treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 23, 2017 , ... PureLife Dental is pleased to announce that California Dental ... As part of the amalgam separator endorsement, all CDA members may purchase an ECO ... the retail value. This partnership between PureLife and CDA is especially timely as it ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... Ulster ... 26th June, 2017 from 9 am to 3 pm to present to graduate students ... program is an original curriculum project led by The Health Improvement Service of ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that offers ... Texas, is announcing the launch of a new charity drive to benefit women in ... United States reveal that an estimated 252, 710 new cases of invasive or high ...
(Date:6/22/2017)... ... 2017 , ... Branches, Inc. has been partnering with The Miami Foundation for ... its programs focused on providing opportunity to low-income families and breaking the cycle of ... of $15,000 to support its , Climb to College & Career initiative which focuses ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited ... about their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, ... silicone rings designed just for you. , From the rock face to the auto ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... BOSTON , June 16, 2017  Exactly 50 years ... kicked off what later became known as the San Francisco ... www.northernlight.com ) is unveiling two radical innovations in strategic market ... summer.  This announcement marks the beginning of Northern Light,s "Summer ... ...
(Date:6/14/2017)... N.C. , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away ... reality platform is described by Forbes as "entering the ... American Medical Association as teaching "empathy to medical professionals ... the startup was recently named a finalist for the ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: